K-ras and p53 alterations in genomic DNA and transcripts of human pancreatic adenocarcinoma cell lines
- PMID: 7961102
- PMCID: PMC5919355
- DOI: 10.1111/j.1349-7006.1994.tb02898.x
K-ras and p53 alterations in genomic DNA and transcripts of human pancreatic adenocarcinoma cell lines
Abstract
We analyzed 15 human pancreatic adenocarcinoma cell lines for alterations of the K-ras and the p53 genes and their transcripts. In 11 cell lines (73.3%), point mutations of the K-ras gene were found at codon 12 in exon 1. In 9 cell lines one allele was mutated and the other was wild type, and both the alleles were expressed into mRNA. In one cell line both alleles of codon 12 were mutated to TGT and GTT, respectively, but only TGT was transcribed into mRNA. Alterations in mRNA of the p53 gene were detected in 10 cell lines (66.7%). Analysis of the genomic sequence of the p53 gene revealed that the alterations consisted of 6 cases of base pair substitutions and 1 case of 1-bp deletion in evolutionarily conserved exons 5 to 8, 2 cases of splicing mutations in exon 4, and 1 case of novel deletion from exons 2 to 9. In 14 cell lines (93.3%), alterations were identified in the K-ras or p53 gene. Of these, 4 cell lines harbored K-ras mutations without p53 alteration, whereas 3 cell lines exhibited p53 alterations without K-ras mutation. Thus, it is suggested that activation of the K-ras gene and inactivation of the p53 gene are strongly and cooperatively associated with pancreatic carcinogenesis.
Similar articles
-
Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.Cancer Res. 1993 Apr 15;53(8):1883-8. Cancer Res. 1993. PMID: 8385572
-
Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.Pancreas. 1996 Jan;12(1):10-7. doi: 10.1097/00006676-199601000-00002. Pancreas. 1996. PMID: 8927612
-
Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.Int J Pancreatol. 1997 Apr;21(2):127-43. doi: 10.1007/BF02822384. Int J Pancreatol. 1997. PMID: 9209954
-
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.Am J Pathol. 1993 Aug;143(2):545-54. Am J Pathol. 1993. PMID: 8342602 Free PMC article. Review.
-
Molecular genetics of exocrine pancreatic neoplasms.Surg Clin North Am. 1995 Oct;75(5):857-69. doi: 10.1016/s0039-6109(16)46732-0. Surg Clin North Am. 1995. PMID: 7660250 Review.
Cited by
-
p53 mutations in two patients with intraductal papillary adenoma of the pancreas.Jpn J Cancer Res. 1996 Dec;87(12):1195-8. doi: 10.1111/j.1349-7006.1996.tb03132.x. Jpn J Cancer Res. 1996. PMID: 9045952 Free PMC article.
-
In vitro models of pancreatic cancer for translational oncology research.Expert Opin Drug Discov. 2009 Apr 1;4(4):429-443. doi: 10.1517/17460440902821657. Expert Opin Drug Discov. 2009. PMID: 20160967 Free PMC article.
-
Specific T-cell immunity against Ki-ras peptides in patients with pancreatic and colorectal cancers.Br J Cancer. 2003 Feb 24;88(4):530-6. doi: 10.1038/sj.bjc.6600697. Br J Cancer. 2003. PMID: 12592366 Free PMC article.
-
Analysis of TP53 mutation status in human cancer cell lines: a reassessment.Hum Mutat. 2014 Jun;35(6):756-65. doi: 10.1002/humu.22556. Epub 2014 May 6. Hum Mutat. 2014. PMID: 24700732 Free PMC article. Review.
-
Alterations in the tumor suppressor genes p53, RB, p16/MTS1, and p15/MTS2 in human pancreatic cancer and hepatoma cell lines.J Gastroenterol. 1997 Feb;32(1):40-6. doi: 10.1007/BF01213295. J Gastroenterol. 1997. PMID: 9058294
References
-
- ) Warshaw , A. L. and Castillo , C. F.Pancreatic carcinoma . N. Engl J. Med. , 326 , 455 – 465 ( 1992. ). - PubMed
-
- ) Ruggeri , B. , Zhang , S.‐Y. , Caamano , J. , Dirado , M. , Flynn , S. D. and Klein‐Szanto , A. J. P.Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb‐1 tumor‐suppressor genes . Oncogene , 7 , 1503 – 1511 ( 1992. ). - PubMed
-
- ) Bishop , J. M.Molecular themes in oncogenesis . Cell , 64 , 235 – 248 ( 1991. ). - PubMed
-
- ) Hruban , R. H. , Van Mansfeld , A. D. M. , Offerhaus , G. J. A. , Van Weering , D. H. J. , Allison , D. C. , Goodman , S. N. , Kensler , T. W. , Bose , K. K. , Cameron , J. and Bos , J. L.K‐ras oncogene activation in adenocarcinoma of the human pancreas . Am. J. Pathol , 143 , 545 – 554 ( 1993. ). - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous